INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Scope & Guideline
Empowering healthcare through cutting-edge pharmacological studies.
Introduction
Aims and Scopes
- Clinical Pharmacokinetics and Pharmacodynamics:
The journal publishes research on the absorption, distribution, metabolism, and excretion (ADME) of drugs, as well as their pharmacological effects, highlighting studies that explore how various factors influence drug behavior in the body. - Therapeutic Drug Monitoring and Optimization:
There is a strong emphasis on studies that assess therapeutic drug monitoring (TDM) practices to optimize medication efficacy and minimize toxicity, particularly in vulnerable populations such as those with renal impairment or undergoing chemotherapy. - Pharmacovigilance and Drug Safety:
The journal includes articles on post-marketing surveillance, adverse drug reactions, and safety profiles of medications, underscoring the importance of pharmacovigilance in clinical practice. - Bioequivalence and Drug Formulation Studies:
Research on the bioequivalence of drug formulations and their implications for therapeutic efficacy is a core area, reflecting the journal's commitment to ensuring that generic and branded medications provide similar therapeutic outcomes. - Impact of Comorbidities on Pharmacotherapy:
The journal frequently publishes studies examining how comorbid conditions affect drug therapy, especially in populations with complex health needs, such as the elderly or those with chronic diseases. - Network Pharmacology and Traditional Medicine:
Emerging themes include the use of network pharmacology to understand drug interactions and the efficacy of traditional medicine, particularly in the context of integrative approaches to therapy.
Trending and Emerging
- COVID-19 Treatment and Drug Interactions:
A significant increase in research related to COVID-19, including drug interactions and treatment efficacy, underscores the pandemic's impact on clinical pharmacology and the urgency for effective therapeutic strategies. - Real-World Evidence and Patient-Centered Research:
There is a growing emphasis on real-world evidence studies that assess drug efficacy and safety in diverse patient populations, moving beyond controlled clinical trial settings to understand practical therapeutic outcomes. - Network Pharmacology and AI in Drug Research:
The utilization of network pharmacology and artificial intelligence to analyze drug interactions and therapeutic targets is gaining traction, indicating a modern approach to drug discovery and personalized medicine. - Polypharmacy and Drug-Drug Interactions:
Research focused on polypharmacy, particularly in geriatric populations, is on the rise, reflecting concerns about adverse drug interactions and the need for careful medication management. - Therapeutic Strategies for Chronic Diseases:
Emerging studies are increasingly addressing therapeutic strategies for managing chronic diseases, such as diabetes and cardiovascular conditions, highlighting the need for tailored pharmacotherapy in these populations.
Declining or Waning
- Basic Pharmacology Studies:
There appears to be a waning interest in basic pharmacological studies that do not directly translate into clinical applications, as the journal increasingly prioritizes research with immediate clinical relevance. - Non-Clinical Trial Research:
The publication of studies that focus solely on non-clinical trial methodologies or theoretical frameworks has decreased, indicating a preference for clinical trial data and real-world evidence. - Historical Drug Use Studies:
Research focusing on historical trends in drug use or retrospective analyses that do not incorporate current clinical guidelines or practices is less frequently featured, suggesting a pivot towards more contemporary, applicable research. - Single-Agent Pharmacotherapy:
There is a noticeable decline in studies examining the effects of single-agent therapies, as the journal increasingly highlights multi-drug regimens and combination therapies that reflect real-world clinical practice. - Pharmacogenomics:
Although pharmacogenomics remains important, there has been a relative decrease in the number of studies dedicated solely to genetic factors influencing drug response, as more integrated approaches are favored.
Similar Journals
CLINICAL PHARMACOKINETICS
Exploring Clinical Insights in PharmacokineticsCLINICAL PHARMACOKINETICS, published by ADIS INT LTD, is a premier journal dedicated to the field of pharmacology, with a distinguished reputation since its inception in 1976. With an impressive impact factor and categorized in the Q1 quartile for both general pharmacology and medical pharmacology, this journal ranks #29 out of 272 and #53 out of 313 in its respective categories in Scopus, highlighting its high academic influence and the quality of research it publishes. CLINICAL PHARMACOKINETICS serves as a vital resource for researchers, professionals, and students interested in the latest advancements in drug metabolism, therapeutic efficacy, and clinical applications of pharmacokinetic studies. As it continues to evolve through 2024 and beyond, the journal remains committed to fostering a deeper understanding of pharmacotherapy and its implications in clinical practice. While it does not currently offer open access, the journal ensures that cutting-edge research is accessible through various academic platforms.
Clinical Pharmacology in Drug Development
Elevating drug development through peer-reviewed excellence.Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.
BRITISH JOURNAL OF PHARMACOLOGY
Pioneering insights into drug mechanisms and therapeutic innovations.British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.
Drug Discoveries and Therapeutics
Shaping the landscape of modern medicine.Drug Discoveries and Therapeutics is a highly regarded journal devoted to the advancement of knowledge in the field of medicine and pharmacology. Published by the International Research & Cooperation Association for Biological & Socio-Sciences Advancement in Tokyo, Japan, this journal serves as a vital resource for researchers, practitioners, and students interested in the latest developments in drug discovery and therapeutic strategies. With a Scopus ranking of #192 out of 826 in the General Medicine category, and positioning itself in the 76th percentile, it demonstrates a significant impact within the scientific community. The journal publishes original research articles, reviews, and innovative studies that address the complexities of drug development, therapeutic efficacy, and clinical applications. Researchers and clinicians can access valuable insights to enhance their practices and inform further studies as it continues to disseminate crucial findings essential for the advancement of medical science.
CLINICAL PHARMACOLOGY & THERAPEUTICS
Advancing pharmacological knowledge for better patient care.CLINICAL PHARMACOLOGY & THERAPEUTICS, published by WILEY, stands at the forefront of pharmacological research, serving as a pivotal resource for researchers, healthcare professionals, and students in the medical field. With its prestigious Q1 rating in both Pharmacology and Pharmacology (medical) categories, and ranking in the top 4% of journals in the field, it provides cutting-edge insights into drug therapy, pharmacokinetics, and innovative treatment strategies. The journal features a wide range of articles, from original research to comprehensive reviews, all aimed at advancing knowledge and clinical practice in pharmacology. With a publication history dating back to 1960 and continuing through 2024, its commitment to excellence is evident in its robust impact factor and high visibility in the academic community. For professionals striving to stay at the forefront of pharmacological advancements, CLINICAL PHARMACOLOGY & THERAPEUTICS remains an essential platform for disseminating and accessing vital research findings.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
Advancing pharmaceutical innovation for tropical health.Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.
INDIAN JOURNAL OF PHARMACOLOGY
Empowering researchers with cutting-edge pharmacological discoveries.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Enhancing Understanding of Pharmacological Treatments and ToxicologyBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.
Clinical Pharmacology-Advances and Applications
Catalyzing Collaboration for Pharmacological ExcellenceClinical Pharmacology-Advances and Applications is a premier open access journal published by DOVE MEDICAL PRESS LTD, based in New Zealand. Since its establishment in 2009, the journal has been dedicated to advancing the field of pharmacology by disseminating innovative research and applications related to medication therapy and patient outcomes. With its notable impact factor and current ranking within the top percentile of pharmacology journals, it provides an invaluable platform for researchers, healthcare professionals, and students to share knowledge and foster collaboration. The journal's content spans a wide range of topics, ensuring coverage of both fundamental and emerging areas in medical pharmacology. As of 2023, it holds a strong position in the Q2 quartile, underscoring its relevance and influence within the scientific community. Authors and readers alike benefit from its open access model, which ensures that critical findings are widely accessible, thereby enhancing the pace of discovery and application in clinical settings.
PHARMACIA
Exploring the frontiers of drug development and therapeutic science.PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.